Moderna Inc (MRNA)

Exchange
NASDAQ
Symbol
MRNA
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: December 12, 2025

  • Open
    29.46
  • High
    30.44
  • Low
    29.40
  • Close
    29.46
  • Volume
    12,263,900

Financial ratios

Dec 31, 2024